日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Profiling the Activity of the Potent and Highly Selective CDK2 Inhibitor BLU-222 Reveals Determinants of Response in CCNE1-Aberrant Ovarian and Endometrial Tumors.

对强效且高选择性的 CDK2 抑制剂 BLU-222 的活性进行分析,揭示了 CCNE1 异常卵巢和子宫内膜肿瘤的反应决定因素

House Nealia C, Brown Victoria E, Chen Maxine, Yuan Liang, Moore Sydney L, Guo Jian, Choi Yoon Jong, Muthuswamy Lakshmi, Ribich Scott, Ramsden Philip, Faia Kerrie L

Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells.

识别出由促血管生成血小板和骨髓来源细胞构成的、能够建立肿瘤支持性宏观环境的管腔型乳腺癌

Kuznetsov Hanna S, Marsh Timothy, Markens Beth A, Castaño Zafira, Greene-Colozzi April, Hay Samantha A, Brown Victoria E, Richardson Andrea L, Signoretti Sabina, Battinelli Elisabeth M, McAllister Sandra S